The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.liverpoolecho.co.uk/news/liverpool-news/everyone-liverpool-tested-covid-19-19210041
As per wfc61
Wilson. I was assuming on average around 3/4 per hospital. I remembered someone posting they were getting 7 at their hospital (this has been posted on this thread since - thanks). So assume some will have only 1 and other larger hospitals could have up to a around 10. The numbers (if I got it right) add up to all 300 being in and used now.
So that’s all 300 machines assuming they are all Q16’s running 12 hours a day. 8 runs a day at 90 mins 14 tests per run. 112 a day each machine equals 33,600 over 300 machines. Though I thought there were some Q32’s in there?
Did anyone see that cheeky trip down to 90p then bounce back? A few stop losses triggered?
Firstly let me start by saying that I am very bullish about where the share price is going. In at just over £4 I averaged down as the share price dropped back earlier in the year. So a lot of faith was put in the company and it has and continues to deliver.
I fully expect further good news for us investors to land on UK care homes, Winterplex, France contracts etc.
The upside far outward any possible downsides in a risk/reward. Especially as we are getting picked up by II’s.
One thing that has been nagging at me as I can’t think of a reason for it and thought someone here might have an answer. Why are the shorts (though reduced - Voleon and the other one) still going even though they are getting burnt badly? Ideas??
Every passing day de-risks the share as NCYT make more and more money. There’s still so much more to come with mergers/acquisitions possible to further strengthen the group with all the free cash flow they have. As a worst case scenario, as I see it, this is a billion pound company going forward. I’ve been thinking of taking some “skin” out of the game ///9not on your level admittedly, but we are all in different positions. But I just keep coming back to the thinking that the upside far outweighs the down.
WinterPlex, Carehome, France, USA, World... So much more to come.
DYOR and GLA holders
Kerry G. Must have been only for a few seconds. The graph of the selling price movement is smoothed out so might not show it if you weren’t on it right at the point it moved. Just like a graph of the last 5 days doesn’t show the detail within each day as it is smoothed out. Hope that makes sense.
Is someone telling CK to sit on his hands and not put out an RNS! :)
https://uspto.report/TM/88896035
No didn’t. Sorry not been keeping up with board so may have been put up before.
Did anyone see that the uk-rtc Abc antibody test had applied for trademark in USA or did I imagine that?
Originally got in here at just over £4 and was there for rise to over a fiver and down to low £2. Shares were Over sold then, partially due to the only bump in the road from a Novacyt POV (only having a single gene test which wasn’t accepted by french - not really their fault) and also the drop in cases in the northern hemisphere.
Cases are unfortunately rapidly rising again. NCYT are ahead of the curve with accurate testing with, importantly, a “proven” distribution network.
An antibody Elisa test, 2 gene Covid test, winterplex multi assay test, massive order from Uk government with likely Further orders.
A 2000 near patient care home trial potentially (likely?) leading to another massive order.
French government orders Due?? (this is an Anglo-French company with most shares on the French Bourse so a story for the French too).
Selling to over 130 countries and making lots of ££££.
And finally a great management team looking to crystallise this growth through acquisitions.
Would you bet against them based on what they have done over the last 9-10 months?